![]() |
|
|
Parkinson's DiseaseReferencesAdams RD, Victor M, Ropper AH. Principles of Neurology. (6th edn). New York: McGraw-Hill; 1997. pp1067–1078. Clarke CE. Parkinson’s Disease in Practice. London: Royal Society of Medicine Press Ltd, 2001. Defer GL, Widner H, Marie RM, et al. Core assessment program for surgical interventional therapies in Fahn S. Parkinsonism. In: Merritt's Textbook of Neurology Rowland LP (ed). (9th edn). Baltimore: William & Wilkins; 1995. pp713–730. Gasser T. Genetics of Gelb DJ, Oliver E, Gilman S. Diagnostic Criteria for Parkinson disease. Arch Neurol 1999;56:33–39. Gibb WRG, Lees AJ. Pathological clues to the cause of Goetz CG, Jankovic J, Koller WC, et al. Preclinical disease. differential diagnosis. Continuum 1995;1:26–61. Goetz CG, Koller WC, Poewe W, et al. Management of Parkinson’s disease: An evidence-based review. Mov Disord 2002;17:S1–S166. Gomez AG, Jorge R, Garcia S, et al. Clinical and pharmacological differences in early- versus late-onset Hely MA, Morris JG, Reid WG, et al. Age at onset: the major determinant of outcome in Hughes AJ, Daniel SE, Ben-Shlomo Y, et al. The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain 2002;125:861–870. Hughes AJ, Daniel SE, Kilford L et al. Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181–184. Jankovic J, McDermott M, Carter l, et al. Variable expression of Koller WC, Hutton JT, Tolosa E, et al. Immediate-release and controlled-release carbidopa/levodopa in PD: a 5-year randomized multicenter study. Neurology 1999;53:1012–1019. Korczyn AD, Brunt ER, Larsen JP, et al. A 3-year randomized trial of ropinirole and bromocriptine in early Langston JW, Widner H, Goetz CG, Brooks, et al. Core assessment program for intracerebral transplantations (CAPIT). Mov Disord 1992;7:2–13. Litvan I, Agid Y, Jankovic J, et al. Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele–Richardson–Olszewski syndrome). Neurology 1996;46:922–930. Litvan I, Bhatia KP, Burn DJ, et al. SIC task force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov Disord 2003;18:467–486. Litvan I, MacIntyre A, Goetz CG, et al. Accuracy of the clinical diagnoses of Lewy body disease, Parkinson disease, and Piccini P, Burn DJ, Ceravolo R, et al. The role of inheritance in National Parkinson’s Foundation. What Are Your Chances of Getting Parkinson Disease? 2002. Poewe WH, Wenning GK. The natural history of Rajput AH, Rozdilsky B, Rajput A. Accuracy of clinical diagnosis in Parkinsonism: a prospective study. Can J Neurol Sci 1991;18:275–278. Schrag A, Ben-Shlotno Y, Brown R, et al. Young-onset The Deep Brain Stimulation for Parkinson’s Disease Study Group. Deep-brain stimulation of the subthalamic nucleus or the pars interna of the glogus pallidus in Parkinson’s disease. N Engl J Med 2001;345:956–963. The Parkinson Disease Study Group. Effect of deprenyl on the progression of disability in early Volkman J, Allert N, Voges J, et al. Safety and efficacy of pallidal or subthalamic nucleus stimulation in advanced PD. Neurology 2002;56:548–551. Ward C and Gibb W. Research diagnostic criteria for Parkinson’s disease. In: Advances in neurology: Parkinson’s disease: Anatomy, Pathology, and Therapy. Streifler M, Korczyn A, Melamed E, Youdim M (eds). New York: Raven Press; 1990. |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||